-
-
A tyrosine kinase inhibitor has been approved for the treatment of medullary thyroid cancer (MTC).
-
The use of low-dose aspirin is associated with an almost two-fold increase in the risk of upper gastrointestinal bleeding compared with nonuse and this risk is further increased when low-dose aspirin is combined with clopidogrel, oral anticoagulants, nonsteroidal anti-inflammatory drugs, or high-dose oral corticosteroids.
-
In a large, randomized, controlled trial, screening for prostate cancer did not have a significant effect on mortality from prostate cancer after 20 years of follow-up.
-
Mindfulness Based Stress Reduction (MBSR) research over 30 years has explored its potential benefits for mood disorders, chronic medical illness, and pain as well as mental and physical health for non-medical populations.
-
You saw the title and probably said to yourself "Really? Another use for the star vitamin, vitamin D?" Indeed; it's true.
-
Weight loss and weight maintenance are often difficult to achieve. Although exercise is recommended as one of the mainstays of treatment, many overweight people have difficulty finding a feasible and enjoyable form of exercise.
-
In the general population, there is a linear and reversible relationship between salt intake and blood pressure (BP): more salt in begets higher BP, and salt restriction lowers BP.
-
An oral selective phosphodiesterase 4 (pde4) inhibi-tor has been approved for the treatment of patients with chronic obstructive pulmonary disease (COPD). Roflumilast is the first drug of this type to be approved for this indication. It is marketed by Forest Pharmaceuticals as Daliresp.
-
The health improvement network UK primary care database was queried for all patients aged 50-84 who were prescribed low-dose aspirin (75-300 mg/day) for the secondary prevention of cardiovascular disease in 2000-2007.